Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.15 USD | -1.57% | +8.12% | +16.75% |
05-07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
05-07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |